VWF and thrombotic thrombocytopenic purpura: Recently, we demonstrated that COVID-19 is associated with a substantial increase in von Willebrand factor (VWF) concentrations, which can exceed the ADAMTS13 processing capacity resulting in the formation of large VWF multimers identical to thrombotic thrombocytopenic purpura (TTP)5,6.